12 Health Care Stocks Moving In Friday's Pre-Market Session

By Benzinga Insights

 

Gainers

  • Absci (NASDAQ:ABSI) shares increased by 51.5% to $9.3 during Friday's pre-market session. The market value of their outstanding shares is at $861.1 million.
  • Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 21.26% to $2.11. The market value of their outstanding shares is at $17.6 million.
  • Exscientia (NASDAQ:EXAI) shares increased by 14.73% to $20.87. The market value of their outstanding shares is at $2.5 billion.
  • BioRestorative Therapies (NASDAQ:BRTX) shares increased by 6.72% to $4.6. The market value of their outstanding shares is at $16.0 million.
  • Abeona Therapeutics (NASDAQ:ABEO) shares rose 5.87% to $0.33. The company's market cap stands at $48.9 million.
  • Ginkgo Bioworks Holdings (NYSE:DNA) shares increased by 5.07% to $7.25. The market value of their outstanding shares is at $12.1 billion.
  •  

Losers

  • Alterity Therapeutics (NASDAQ:ATHE) stock fell 9.9% to $1.0 during Friday's pre-market session. The company's market cap stands at $40.1 million.
  • Freeline Therapeutics (NASDAQ:FRLN) shares decreased by 9.1% to $1.8. The company's market cap stands at $64.4 million.
  • Lixte Biotech Holdings (NASDAQ:LIXT) shares declined by 7.21% to $2.06. The market value of their outstanding shares is at $28.3 million.
  • Immix Biopharma (NASDAQ:IMMX) stock fell 7.11% to $5.1. The company's market cap stands at $38.6 million.
  • Plus Therapeutics (NASDAQ:PSTV) shares declined by 6.82% to $1.23. The market value of their outstanding shares is at $18.8 million.
  • Nutriband (NASDAQ:NTRB) stock decreased by 6.14% to $6.27. The market value of their outstanding shares is at $48.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.


What is inkl?

Important stories

See news based on value, not advertising potential. Get the latest news from around the world.

Trusted newsrooms

We bring you reliable news from the world’s most experienced journalists in the most trusted newsrooms.

Ad-free reading

Read without interruptions, distractions or intrusions of privacy.